dimethylbenzylamine structure
|
Common Name | dimethylbenzylamine | ||
|---|---|---|---|---|
| CAS Number | 103-83-3 | Molecular Weight | 135.206 | |
| Density | 0.9±0.1 g/cm3 | Boiling Point | 181.0±0.0 °C at 760 mmHg | |
| Molecular Formula | C9H13N | Melting Point | -75 °C | |
| MSDS | Chinese USA | Flash Point | 54.4±0.0 °C | |
| Symbol |
GHS02, GHS05, GHS07 |
Signal Word | Danger | |
| Name | N,N-Dimethylbenzylamine |
|---|---|
| Synonym | More Synonyms |
| Density | 0.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 181.0±0.0 °C at 760 mmHg |
| Melting Point | -75 °C |
| Molecular Formula | C9H13N |
| Molecular Weight | 135.206 |
| Flash Point | 54.4±0.0 °C |
| Exact Mass | 135.104797 |
| PSA | 3.24000 |
| LogP | 1.98 |
| Vapour Pressure | 0.9±0.3 mmHg at 25°C |
| Index of Refraction | 1.517 |
| Stability | Stable. Incompatible with strong acids, strong oxidizing agents. |
| Water Solubility | 8 g/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS02, GHS05, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H226-H302 + H312 + H332-H314-H412 |
| Precautionary Statements | P273-P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | C:Corrosive |
| Risk Phrases | R10;R20/21/22;R34;R52/53 |
| Safety Phrases | S26-S36-S45-S61 |
| RIDADR | UN 2619 8/PG 2 |
| WGK Germany | 2 |
| RTECS | DP4500000 |
| Packaging Group | II |
| Hazard Class | 8 |
| HS Code | 2921499090 |
| Precursor 9 | |
|---|---|
| DownStream 10 | |
| HS Code | 2921499090 |
|---|---|
| Summary | 2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
|
Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and type-II epithelial cells.
Nanoscale 7 , 10398-409, (2015) Inhaled nanoparticles have a high deposition rate in the alveolar units of the deep lung. The alveolar epithelium is composed of type-I and type-II epithelial cells (ATI and ATII respectively) and is ... |
|
|
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
J. Med. Chem. 52 , 3416-9, (2009) RPLC gains acceptance in pharmaceutical research for the rapid determination of lipophilicity but remains limited for the determination of partition coefficients of moderate to strong basic compounds ... |
|
|
Benzylamine analog binding studies as probes of the substrate sites of monoamine oxidases A and B.
Drug Metab. Rev. 31(1) , 235-45, (1999)
|
| dimethylbenzylamine |
| N,N-Dimethylbenzylam |
| N-BENZYLDIETHYLAMINE |
| Pentamin BDMA etc |
| Benzyldimethylamine |
| BENZYLDIETHYLAMINE |
| Dabco B-16 |
| dimethylaminomethylbenzene |
| BDMA |
| EINECS 203-149-1 |
| Benzenemethanamine, N,N-dimethyl- |
| N,N-dimethyl-N-benzylamine |
| N,N-dimethylphenylmethanamine |
| N-benzyl-N,N-dimethylamine |
| benzyl-N,N-dimethylamine |
| N-Benzyldimethylamine |
| N,N-Dimethyl-1-phenylmethanamine |
| MFCD00026731 |
| N,N-Dimethylbenzylamine |
| Sumine 2015 |
| AURORA KA-7522 |
| benzyl dimethyl amine |